Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

The neurocognitive effects of Hypericum perforatum Special Extract (Ze 117) during smoking cessation.

Camfield DA, Scholey AB, Pipingas A, Silberstein RB, Kure C, Zangara A, Kras M, Stough C.

Phytother Res. 2013 Nov;27(11):1605-13. doi: 10.1002/ptr.4909. Epub 2012 Dec 19.

PMID:
23280675
[PubMed - indexed for MEDLINE]
2.

Hypericum perforatum attenuates nicotine withdrawal signs in mice.

Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapai G.

Psychopharmacology (Berl). 2003 Sep;169(2):186-9. Epub 2003 Apr 29.

PMID:
12719964
[PubMed - indexed for MEDLINE]
3.

Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.

Mannucci C, Pieratti A, Firenzuoli F, Caputi AP, Calapai G.

Phytomedicine. 2007 Oct;14(10):645-51. Epub 2007 Aug 6.

PMID:
17689233
[PubMed - indexed for MEDLINE]
4.

A randomized clinical trial of St. John's wort for smoking cessation.

Sood A, Ebbert JO, Prasad K, Croghan IT, Bauer B, Schroeder DR.

J Altern Complement Med. 2010 Jul;16(7):761-7. doi: 10.1089/acm.2009.0445.

PMID:
20590478
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Nicotine replacement therapy for smoking cessation.

Silagy C, Mant D, Fowler G, Lancaster T.

Cochrane Database Syst Rev. 2000;(3):CD000146. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD000146.

PMID:
10908462
[PubMed - indexed for MEDLINE]
6.

Effects of the nicotine patch on performance during the first week of smoking cessation.

Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC.

Nicotine Tob Res. 2003 Apr;5(2):169-80. Review.

PMID:
12745489
[PubMed - indexed for MEDLINE]
7.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;5:CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
[PubMed - indexed for MEDLINE]
8.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
[PubMed - indexed for MEDLINE]
9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
[PubMed - indexed for MEDLINE]
10.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200
[PubMed - indexed for MEDLINE]
11.
12.

A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.

Becker KM, Rose JE, Albino AP.

Nicotine Tob Res. 2008 Jul;10(7):1139-48. doi: 10.1080/14622200802123294.

PMID:
18629723
[PubMed - indexed for MEDLINE]
13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006103. doi: 10.1002/14651858.CD006103.pub6. Review.

PMID:
22513936
[PubMed - indexed for MEDLINE]
14.

The effects of exercise and nicotine replacement therapy on smoking rates in women.

Prapavessis H, Cameron L, Baldi JC, Robinson S, Borrie K, Harper T, Grove JR.

Addict Behav. 2007 Jul;32(7):1416-32. Epub 2006 Nov 9.

PMID:
17097814
[PubMed - indexed for MEDLINE]
15.

Steady state visually evoked potential (SSVEP) topography changes associated with cocoa flavanol consumption.

Camfield DA, Scholey A, Pipingas A, Silberstein R, Kras M, Nolidin K, Wesnes K, Pase M, Stough C.

Physiol Behav. 2012 Feb 28;105(4):948-57. doi: 10.1016/j.physbeh.2011.11.013. Epub 2011 Nov 19.

PMID:
22120044
[PubMed - indexed for MEDLINE]
16.

Hypericum perforatum and substance dependence: a review.

Uzbay TI.

Phytother Res. 2008 May;22(5):578-82. doi: 10.1002/ptr.2420. Review.

PMID:
18350514
[PubMed - indexed for MEDLINE]
17.

Reduced NRT supplies through a quitline: smoking cessation differences.

Burns EK, Tong S, Levinson AH.

Nicotine Tob Res. 2010 Aug;12(8):845-9. doi: 10.1093/ntr/ntq094. Epub 2010 Jun 18.

PMID:
20562205
[PubMed - indexed for MEDLINE]
18.

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.

Aubin HJ, Bobak A, Britton JR, Oncken C, Billing CB Jr, Gong J, Williams KE, Reeves KR.

Thorax. 2008 Aug;63(8):717-24. doi: 10.1136/thx.2007.090647. Epub 2008 Feb 8.

PMID:
18263663
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory.

Carlson JM, Gilbert DG, Riise H, Rabinovich NE, Sugai C, Froeliger B.

Exp Clin Psychopharmacol. 2009 Jun;17(3):173-80. doi: 10.1037/a0016384.

PMID:
19586232
[PubMed - indexed for MEDLINE]
20.

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.

Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.

Psychopharmacology (Berl). 2002 Nov;164(2):177-87. Epub 2002 Aug 27.

PMID:
12404080
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk